Stock VIV AVIVAGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Avivagen Inc.

Equities

VIV

CA05382F2026

Delayed Toronto S.E.
Other stock markets
 08:00:00 05/03/2024 pm IST 		5-day change 1st Jan Change
0.005 CAD -.--% Intraday chart for Avivagen Inc. -.--% -.--%
2023 Avivagen Inc. Announces New 500 Kg Order for OxC-beta CI
2023 Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Avivagen Inc. Announces New 500 Kg Order for OxC-beta
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
Avivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta? Livestock Product
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
Avivagen Inc. Announces Significant Increase in Sales to an Existing Customer
Avivagen Announces Review of Strategic Alternatives
Avivagen Inc. Announces Board Changes
Avivagen Narrows Fiscal Q1 Loss, Revenue Falls; Says Will Need Cash Proceeds to Continue as Going Concern
Avivagen Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023
Avivagen Inc. Reports Earnings Results for the Full Year Ended October 31, 2022
Avivagen Inc. Auditor Raises 'Going Concern' Doubt
Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022
Avivagen anuncia su nuevo cliente de productos lácteos en México
Avivagen Reports New Customer in Mexico; Up 8.6%
Avivagen Inc. Secures New Customer in the Mexican Dairy Industry
Avivagen Inc. Announces Receipt of Repeat Order from Asian Customer
Avivagen Inc. Secures Order for OxC-beta from AB Vista
Avivagen Inc. Announces Sales of Companion Animal Product and 6,000 pouches order through new and existing customers in Taiwan and Mexico
Avivagen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022
Avivagen Announces Successful Completion of Formal Safety and Toxicology Evaluation of Fully Oxidized Beta-Carotene
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIV Stock
  4. News Avivagen Inc.
  5. Other languages